CoChat

Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission

Liu, Liehua, Ke, Weijian, Wan, Xuesi, Zhang, Pengyuan, Cao, Xiaopei, Deng, Wanping, Li, Yanbing · 2015 · Diabetes Research and Clinical Practice
Cited by 25

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2015.02.011

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 27

  1. Xu, 2013, Prevalence and control of diabetes in Chinese adults, JAMA, 310, 948, 10.1001/jama.2013.168118 · DOI · Paper page
  2. UK Prospective Diabetes Study (UKPDS) Group, 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 · DOI · Paper page
  3. Holman, 2008, 10-Year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, 359, 1577, 10.1056/NEJMoa0806470 · DOI · Paper page
  4. Kahn, 2006, Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy, N Engl J Med, 355, 2427, 10.1056/NEJMoa066224 · DOI · Paper page
  5. Li, 2004, Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function, Diabetes Care, 27, 2597, 10.2337/diacare.27.11.2597 · DOI · Paper page
  6. Son, 2013, The Effect of early intensive insulin therapy on body fat distribution and beta-cell function in newly diagnosed type 2 diabetes, Endocr Res, 38, 160, 10.3109/07435800.2012.745870 · DOI
  7. Hu, 2011, Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and beta-cell function in subjects with long-term remission, Diabetes Care, 34, 1848, 10.2337/dc10-2105 · DOI · Paper page
  8. Kramer, 2013, Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis, Lancet Diabetes Endocrinol, 1, 28, 10.1016/S2213-8587(13)70006-8 · DOI · Paper page
  9. Chinese guidline for type 2 diabetes—2013. Chin J Diabetes Mellitus 2014; 6:447–498, http://dx.doi.org/10.3760/cma.j.issn.1674-5809.2014.07.004 · DOI
  10. Liu, 2013, Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients, Endocr J, 60, 725, 10.1507/endocrj.EJ12-0315 · DOI
  11. Liu, 2012, Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy, Diabetes Technol Ther, 14, 756, 10.1089/dia.2012.0055 · DOI
  12. Xu, 2009, Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study, Chin Med J (Engl), 122, 2554
  13. Huang, 2013, Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant alpha-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus, Diabetes Technol Ther, 15, 859, 10.1089/dia.2013.0013 · DOI
  14. Noh, 2010, Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion, Diabetes Technol Ther, 12, 271, 10.1089/dia.2009.0131 · DOI
  15. Gao, 2011, Investigation of the insulin dose and characteristics of continuous subcutaneous insulin infusion in Chinese people with type 2 diabetes, Diabetes Technol Ther, 13, 1135, 10.1089/dia.2011.0109 · DOI
  16. Cai, 2012, Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatment, PLoS ONE, 7, e38962, 10.1371/journal.pone.0038962 · DOI
  17. Kuroda, 2011, Basal insulin requirement is ∼30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump, Diabetes Care, 34, 1089, 10.2337/dc10-2149 · DOI
  18. Yang, 2014, Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial, Lancet Diabetes Endocrinol, 2, 46, 10.1016/S2213-8587(13)70021-4 · DOI · Paper page
  19. Papa, 2012, Factors that influence basal insulin requirement in type 2 diabetes, Acta Diabetol, 49, 387, 10.1007/s00592-012-0372-7 · DOI
  20. Wittlin, 2006, Treating the spectrum of type 2 diabetes: emphasis on insulin pump therapy, Diabetes Educ, 32, 39S, 10.1177/0145721705285642 · DOI
  21. Nathan, 2009, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025 · DOI · Paper page
  22. Tang, 2001, Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes, Diabetes, 50, 83, 10.2337/diabetes.50.1.83 · DOI
  23. Kim, 2011, Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes, Diabetes Res Clin Pract, 93, 174, 10.1016/j.diabres.2011.04.009 · DOI
  24. Biesenbach, 2006, Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI, Diabetes Obes Metab, 8, 669, 10.1111/j.1463-1326.2005.00552.x · DOI
  25. Chen, 2012, Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment, Diabetes Care, 35, 474, 10.2337/dc11-1638 · DOI
  26. Bhattacharya, 2011, Recovery of beta-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients, Diabetes Technol Ther, 13, 461, 10.1089/dia.2010.0187 · DOI
  27. Harrison, 2014, Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial, J Investig Med, 62, 676, 10.2310/JIM.0000000000000068 · DOI

Metadata

Authors
Liu, L., Ke, W., Wan, X., Zhang, P., Cao, X., Deng, W., & Li, Y.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2015-05
Volume
108
Issue
2
Pages
250-257
ISSN
0168-8227
Cited by
25
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • SunYat-sen University (1346000270, 2012A030400006)
  • Ministry of Education (20130171110067)
  • Health Department of Guangdong Province

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission. https://app.cochat.ai/papers/10.1016/j.diabres.2015.02.011
The paper
Liu, L., Ke, W., Wan, X., Zhang, P., Cao, X., Deng, W., & Li, Y. (2015). Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2015.02.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.